dc.contributor.author
Alonso Padilla, Julio
dc.contributor.author
Gállego Culleré, M. (Montserrat)
dc.contributor.author
Schijman, Alejandro G.
dc.contributor.author
Gascón i Brustenga, Joaquim
dc.date.issued
2023-12-11T11:50:37Z
dc.date.issued
2023-12-11T11:50:37Z
dc.date.issued
2017-06-09
dc.date.issued
2023-12-11T11:50:37Z
dc.identifier
https://hdl.handle.net/2445/204332
dc.description.abstract
Chagas disease is caused by the parasite Trypanosoma cruzi. It affects 7 million people, mainly in Latin America. Diagnosis is usually made serologically, but at some clinical scenarios serology cannot be used. Then, molecular detection is required for early detection of congenital transmission, treatment response follow up, and diagnosis of immune-suppression reactivation. However, present tests are technically demanding and require well-equipped laboratories which make them unfeasible in low-resources endemic regions.
dc.format
application/pdf
dc.publisher
Taylor & Francis
dc.relation
Versió postprint del document publicat a: https://doi.org/10.1080/14737159.2017.1338566
dc.relation
Expert Review Of Molecular Diagnostics, 2017, vol. 17, num.7, p. 699-710
dc.relation
https://doi.org/10.1080/14737159.2017.1338566
dc.rights
(c) Taylor & Francis, 2017
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Biologia, Sanitat i Medi Ambient)
dc.subject
Genètica molecular
dc.subject
Malaltia de Chagas
dc.subject
Molecular genetics
dc.subject
Chagas' disease
dc.title
Molecular diagnostics for Chagas disease: up to date and novel methodologies
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion
